CSTL Past Earnings image   This CSTL past earnings page last updated 8/10/2022
CSTL Past Earnings
PeriodPast Earnings DateAdj. EPS
Q2 20228/8/2022-0.770
Q1 20225/9/2022-0.970
Q4 20212/28/2022-0.250
Q3 202111/8/2021-0.470
Q2 20218/9/2021-0.340
Q1 20215/10/2021-0.170
Q4 20203/8/2021-0.170
Q3 202011/9/2020-0.230
Q2 20208/10/2020-0.080
Q1 20205/11/20200.030
Q4 20193/10/20200.110
Q3 201911/11/20190.020
Q2 20199/3/2019-1.050
CSTL Past Revenue
PeriodPast Earnings DateGAAP
Q2 20228/8/20220.03B
Q1 20225/9/20220.03B
Q4 20212/28/20220.03B
Q3 202111/8/20210.02B
Q2 20218/9/20210.02B
Q1 20215/10/20210.02B
Q4 20203/8/20210.02B
Q3 202011/9/20200.02B
Q2 20208/10/20200.01B
Q1 20205/11/20200.02B
Q4 20193/10/20200.02B
Q3 201911/11/20190.01B
Q2 20199/3/20190.01B
Quotes delayed 20 minutes

Email EnvelopeFree CSTL Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Castle Biosciences (CSTL) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

CSU Past Earnings
CTIC Past Earnings
CTKB Past Earnings
CTLT Past Earnings
CTMX Past Earnings
CTSO Past Earnings
CTXR Past Earnings
CUE Past Earnings
CUTR Past Earnings
CVRX Past Earnings

CSTL Past Earnings Q&A

What was the best and worst CSTL past earnings results?
For Castle Biosciences, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest CSTL past earnings result in our data set was 0.110/share posted in Q4 2019, while the lowest was in Q2 2019 when CSTL posted -1.050/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q2 2022 when CSTL reported 0.03B in revenue, while the quarter with the lowest revenue in our data set was Q2 2019 at 0.01B of revenue.

  Suggested answer: There are 13 CSTL past earnings results in our data set.

On this page we presented the CSTL past earnings date information for Castle Biosciences. Reviewing that CSTL Past Earnings for the company, we see that the highest past earnings result in our data set was in Q4 2019, when CSTL posted adjusted EPS of 0.110/share. Meanwhile the lowest CSTL past earnings result was in Q2 2019, when CSTL posted adjusted EPS of -1.050/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q2 2022 when CSTL reported 0.03B in revenue, while the smallest revenue quarter was Q2 2019 when CSTL reported 0.01B in revenue.

Any self directed investor doing their due diligence on CSTL or any other given stock can benefit from researching all of the Castle Biosciences past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Castle Biosciences past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for CSTL. Thanks for visiting, and the next time you need to research CSTL past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: GPMT market cap history, Funds Holding PBEE, Funds Holding RVM.

 

CSTL Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.